ECHO THERAPEUTICS Total Debt Trend from 2010 to 2022

ECTE -  USA Stock  

USD 0.0002  0.00  0.00%

ECHO THERAPEUTICS Total Debt is increasing over the years with slightly volatile fluctuation. Ongoing Total Debt is projected to grow to about 409.5 K this year. During the period from 2010 to 2022 ECHO THERAPEUTICS Total Debt anual values regression line had geometric mean of 139,413 and significance of  0.00054207. ECHO THERAPEUTICS Interest Expense is projected to decrease significantly based on the last few years of reporting. The past year's Interest Expense was at 17,644.45. The current year Preferred Dividends Income Statement Impact is expected to grow to about 323.3 K, whereas Earning Before Interest and Taxes EBIT is forecasted to decline to (21.5 M).

ECHO THERAPEUTICS Historical Trends 

 
Refresh
Check ECHO THERAPEUTICS financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among ECHO THERAPEUTICS main balance sheet or income statement drivers, such as Gross Profit of 52.9 K, Interest Expense of 18.1 K or Operating Expenses of 18.2 M, as well as many exotic indicators such as Asset Turnover of 0.0028, Current Ratio of 0.0859 or Gross Margin of 0.89. ECHO THERAPEUTICS financial statements analysis is a perfect complement when working with ECHO THERAPEUTICS Valuation or Volatility modules. It can also supplement various ECHO THERAPEUTICS Technical models. Continue to Investing Opportunities.

ECHO THERAPEUTICS Quarterly Total Debt

3.52 MillionShare

ECHO THERAPEUTICS Total Debt Breakdown

Showing smoothed Total Debt of ECHO THERAPEUTICS INC with missing and latest data points interpolated. Total Debt of ECHO THERAPEUTICS INC is a combination of both ECHO THERAPEUTICS short-term and long-term liabilities. Short-term debts are those that must be paid back within a year. This type of debt applies to things like lines of credit or short-term term bonds. Long-term debt of ECHO THERAPEUTICS INC includes liability that must be paid off in more than a year. This typically includes large senior debts like mortgages, bonds, as well as business loans or leases. A component of Total Liabilities representing the total amount of current and non-current debt owed. Includes secured and unsecured bonds issued; commercial paper; notes payable; credit facilities; lines of credit; capital lease obligations; operating lease obligations; and convertible notes.ECHO THERAPEUTICS's Total Debt historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in ECHO THERAPEUTICS's overall financial position and show how it may be relating to other accounts over time.
ViewLast Reported 3.52 M10 Years Trend
Increasing
Slightly volatile
 Total Debt 
Share
      Timeline 

ECHO THERAPEUTICS Total Debt Regression Statistics

Arithmetic Mean 256,882
Geometric Mean 139,413
Coefficient Of Variation 55.45
Mean Deviation 121,080
Median 330,000
Standard Deviation 142,432
Range 408,100
R-Value 0.82
R-Squared 0.68
Significance 0.00054207
Slope 30,115

ECHO THERAPEUTICS Total Debt History

2010108.2 K
2011  6,176 
2012124.7 K
2013  1,361 
2014330 K
2021379.5 K
2022409.5 K

Other Fundumenentals of ECHO THERAPEUTICS INC

ECHO THERAPEUTICS Total Debt component correlations

About ECHO THERAPEUTICS Financial Statements

There are typically three primary documents that fall into the category of financial statements. These documents include ECHO THERAPEUTICS income statement, its balance sheet, and the statement of cash flows. ECHO THERAPEUTICS investors use historical funamental indicators, such as ECHO THERAPEUTICS's Total Debt, to determine how well the company is positioned to perform in the future. Although ECHO THERAPEUTICS investors may use each financial statement separately, they are all related. The changes in ECHO THERAPEUTICS's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on ECHO THERAPEUTICS's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on ECHO THERAPEUTICS Financial Statements. Understanding these patterns can help to make the right decision on long term investment in ECHO THERAPEUTICS. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for 2022
Total Debt379.5 K409.5 K
Echo Therapeutics, Inc. engages in the development of transdermal skin permeation and diagnostic medical devices for wearable-health consumer and diabetes outpatient markets. The company was founded in 1989 and is headquartered in Iselin, New Jersey. Echo Therapeutics operates under Medical Devices classification in the United States and is traded on OTC Exchange. It employs 19 people.

ECHO THERAPEUTICS Investors Sentiment

The influence of ECHO THERAPEUTICS's investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in ECHO THERAPEUTICS. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock markets does not have a solid backing from leading economists and market statisticians.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards ECHO THERAPEUTICS in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, ECHO THERAPEUTICS's short interest history, or implied volatility extrapolated from ECHO THERAPEUTICS options trading.

Current Sentiment - ECTE

ECHO THERAPEUTICS INC Investor Sentiment

Most of Macroaxis users are currently bullish on ECHO THERAPEUTICS INC. What is your opinion about investing in ECHO THERAPEUTICS INC? Are you bullish or bearish?
Bullish
Bearish
98% Bullish
2% Bearish
Skip

Pair Trading with ECHO THERAPEUTICS

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if ECHO THERAPEUTICS position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in ECHO THERAPEUTICS will appreciate offsetting losses from the drop in the long position's value.

ECHO THERAPEUTICS Pair Correlation

Equities Pair Trading Analysis

Correlation analysis and pair trading evaluation for ECHO THERAPEUTICS and Bio-Rad Laboratories. Pair trading can be used as a hedging technique within a particular sector or industry or even over random equities to generate better risk-adjusted return
Run Pair Correlation  
Continue to Investing Opportunities. Note that the ECHO THERAPEUTICS INC information on this page should be used as a complementary analysis to other ECHO THERAPEUTICS's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Alpha Finder module to use alpha and beta coefficients to find investment opportunities after accounting for the risk.

Other Tools for ECHO THERAPEUTICS Stock

When running ECHO THERAPEUTICS INC price analysis, check to measure ECHO THERAPEUTICS's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ECHO THERAPEUTICS is operating at the current time. Most of ECHO THERAPEUTICS's value examination focuses on studying past and present price action to predict the probability of ECHO THERAPEUTICS's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move ECHO THERAPEUTICS's price. Additionally, you may evaluate how the addition of ECHO THERAPEUTICS to your portfolios can decrease your overall portfolio volatility.
Equity Valuation
Check real value of public entities based on technical and fundamental data
Go
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Go
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Go
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Go
Commodity Channel Index
Use Commodity Channel Index to analyze current equity momentum
Go
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Go
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Go
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Go
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Go
Focused Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Go